This inventor holds 22 USPTO granted patents and 3 published patent applications. Top assignees: Cancer Research Technology Limited, The Institute of Cancer Research, Vernalis &r&d) Ltd.. Active years: 2004-2022.
Location History:
- Banstead, GB (2005 - 2009)
- Surrey, GB (2006 - 2010)
- Reigate Surrey, GB (2013)
- Reigate, GB (2004 - 2014)
- Sutton, GB (2012 - 2014)
- London, GB (2007 - 2022)
Company Filing History:
16 out of 268 
8 out of 24 
5 out of 68 
Years Active: 2004-2022
Title: **The Innovative Journey of Edward McDonald: A Pioneer in Cancer Research**
Introduction
Edward McDonald, based in Surrey, GB, is a remarkable inventor known for his contributions to cancer research and therapeutic innovations. With a portfolio boasting 22 patents, McDonald has dedicated his career to developing novel compounds that target critical biological processes in cancer treatment.
Latest Patents
Among his latest innovations is the patent concerning the use of isoxazole compounds as inhibitors of heat shock proteins (HSP90). His work focuses on the intricate design of isoxazoles of specific formula which serve as inhibitors of HSP90 activity, showcasing potential applications in treating various cancers. The compounds feature complex structural elements, including aryl and heteroaryl radicals, along with C-Calkylene and C-Calkenylene components, which contribute to their functionality as effective therapeutic agents.
Career Highlights
McDonald's expansive career is marked by his significant work with prominent institutions such as Cancer Research Technology Limited and The Institute of Cancer Research. His dedication has not only generated a substantial number of patents but has also propelled advancements in cancer therapies, reflecting his commitment to improving patient outcomes.
Collaborations
Throughout his career, McDonald has collaborated with esteemed colleagues, including Martin James Drysdale and Brian William Dymock. These partnerships have allowed for the pooling of expertise, enhancing the impact of their shared research endeavors in the field of cancer treatment.
Conclusion
In summary, Edward McDonald's innovative contributions to the realm of cancer research through his numerous patents signify his role as a pivotal figure in the fight against cancer. His latest patents, particularly in the area of isoxazole compounds, exemplify his ongoing commitment to harnessing scientific innovation for transformative medical solutions.